Julia H. Cochran

507 total citations
15 papers, 358 citations indexed

About

Julia H. Cochran is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Julia H. Cochran has authored 15 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Julia H. Cochran's work include Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (8 papers) and Glycosylation and Glycoproteins Research (6 papers). Julia H. Cochran is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), HER2/EGFR in Cancer Research (8 papers) and Glycosylation and Glycoproteins Research (6 papers). Julia H. Cochran collaborates with scholars based in United States. Julia H. Cochran's co-authors include Robert P. Lyon, Peter D. Senter, Jessica K. Simmons, Patrick Burke, Kim K. Emmerton, Scott C. Jeffrey, Weiping Zeng, Ivan J. Stone, Joshua H. Hunter and Jamie B. Miyamoto and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Nature Biotechnology.

In The Last Decade

Julia H. Cochran

15 papers receiving 346 citations

Peers

Julia H. Cochran

ONCOL

RNMI

MB

OC

BE

Kim K. Emmerton United States

Komal Mandleywala United States

Rémy Gébleux Switzerland

Summer Y.Y. Ha Hong Kong

Xuesai Zhang China

Katelyn E. McCabe United States

Mike Cornejo United States

Hanieh Khalili United Kingdom

Stefanie Pektor Germany

Kim K. Emmerton United States

Julia H. Cochran

414 ×2.0

ONCOL

334 ×1.8

RNMI

211 ×1.3

MB

87 ×1.7

OC

48 ×1.0

BE

Citations per year, relative to Julia H. Cochran Julia H. Cochran (= 1×) peers Kim K. Emmerton

Countries citing papers authored by Julia H. Cochran

Since Specialization

Citations

This map shows the geographic impact of Julia H. Cochran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia H. Cochran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia H. Cochran more than expected).

Fields of papers citing papers by Julia H. Cochran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia H. Cochran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia H. Cochran. The network helps show where Julia H. Cochran may publish in the future.

Co-authorship network of co-authors of Julia H. Cochran

This figure shows the co-authorship network connecting the top 25 collaborators of Julia H. Cochran. A scholar is included among the top collaborators of Julia H. Cochran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia H. Cochran. Julia H. Cochran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Hamblett, Kevin J., Julia H. Cochran, Roma Yumul, et al.. (2023). SGN-35C: A Novel CD30-Directed Antibody-Drug Conjugate for the Treatment of Lymphomas. Blood. 142(Supplement 1). 1440–1440. 3 indexed citations

2.

Simmons, Jessica K., et al.. (2020). Reducing the antigen-independent toxicity of antibody-drug conjugates by minimizing their non-specific clearance through PEGylation. Toxicology and Applied Pharmacology. 392. 114932–114932. 52 indexed citations

3.

Liu, Bernard A., John J. Gosink, Anthony Cao, et al.. (2020). Abstract 5581: Enfortumab vedotin, an anti-Nectin-4 ADC demonstrates bystander cell killing and immunogenic cell death anti-tumor activity mechanisms of action in urothelial cancers. Cancer Research. 80(16_Supplement). 5581–5581. 24 indexed citations

4.

Cochran, Julia H., et al.. (2020). Abstract 2895: Characterization of payload release from a novel camptothecin drug-linker. Cancer Research. 80(16_Supplement). 2895–2895. 1 indexed citations

5.

Mitchell, Jamie, Julia H. Cochran, Kim K. Emmerton, et al.. (2020). Improving Antibody‐Tubulysin Conjugates through Linker Chemistry and Site‐Specific Conjugation. ChemMedChem. 16(7). 1077–1081. 11 indexed citations

6.

Li, Fu, Michelle Ulrich, Vincent Feng-Sheng Shih, et al.. (2019). Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody–Drug Conjugate Via Fc–FcγR Interaction. Molecular Cancer Therapeutics. 18(4). 780–787. 37 indexed citations

7.

Zhang, Xinqun, Roma Yumul, Weiping Zeng, et al.. (2019). A coiled-coil masking domain for selective activation of therapeutic antibodies. Nature Biotechnology. 37(7). 761–765. 64 indexed citations

8.

Neumann, Christopher S., Martha E. Anderson, Julia H. Cochran, et al.. (2018). Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 17(12). 2633–2642. 32 indexed citations

9.

Liu, Bernard A., Anthony Cao, Jesse L. Gurgel, et al.. (2018). Abstract 5619: Additional mechanisms of action of SGN-CD48A in multiple myeloma and improved antitumor activity in combination with daratumumab. Cancer Research. 78(13_Supplement). 5619–5619. 4 indexed citations

10.

Lau, Uland Y., et al.. (2018). Lactone Stabilization is Not a Necessary Feature for Antibody Conjugates of Camptothecins. Molecular Pharmaceutics. 15(9). 4063–4072. 13 indexed citations

11.

Epps, Heather Van, Martha E. Anderson, Changpu Yu, et al.. (2018). Abstract 3833: SEA-BCMA: A highly active enhanced antibody for multiple myeloma. Cancer Research. 78(13_Supplement). 3833–3833. 7 indexed citations

12.

Burke, Patrick, Joshua H. Hunter, Julia H. Cochran, et al.. (2017). Abstract 56: Antibody-drug conjugates containing glucuronide-tubulysin payloads display activity in MDR+ and heterogeneous tumor models. Cancer Research. 77(13_Supplement). 56–56. 1 indexed citations

13.

Burke, Patrick, Jocelyn R. Setter, Joshua H. Hunter, et al.. (2016). Development of Novel Quaternary Ammonium Linkers for Antibody–Drug Conjugates. Molecular Cancer Therapeutics. 15(5). 938–945. 45 indexed citations

14.

Kolakowski, Robert V., Kim K. Emmerton, Chris Leiske, et al.. (2016). The Methylene Alkoxy Carbamate Self‐Immolative Unit: Utilization for the Targeted Delivery of Alcohol‐Containing Payloads with Antibody–Drug Conjugates. Angewandte Chemie. 128(28). 8080–8083. 8 indexed citations

15.

Kolakowski, Robert V., Kim K. Emmerton, Chris Leiske, et al.. (2016). The Methylene Alkoxy Carbamate Self‐Immolative Unit: Utilization for the Targeted Delivery of Alcohol‐Containing Payloads with Antibody–Drug Conjugates. Angewandte Chemie International Edition. 55(28). 7948–7951. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact